Pila Pharma AB operates as a clinical stage biotechnology company. It develops pharmaceutical products for the treatment of diabetes. The company was founded by Dorte Xenia Gram in 2014 and is headquartered in Malmo, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company